Related references
Note: Only part of the references are listed.Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs
Anders N. Kristoffersson et al.
PHARMACEUTICAL RESEARCH (2016)
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
Neang S. Ly et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
A Proposal of a Pharmacokinetic/pharmacodynamic (PK/PD) Index Map for Selecting an Optimal PK/PD Index from Conventional Indices (AUC/MIC, Cmax/MIC, and TAM) for Antibiotics
Yoshiaki Kitamura et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
Ami F. Mohamed et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Combination therapy for carbapenem-resistant Gram-negative bacteria
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
Oren Zusman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Quantifying Subpopulation Synergy for Antibiotic Combinations via Mechanism-Based Modeling and a Sequential Dosing Design
Cornelia B. Landersdorfer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Elisabet I. Nielsen et al.
PHARMACOLOGICAL REVIEWS (2013)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
Celine Vidaillac et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Zakuan Z. Deris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics
Alasdair MacGowan
CURRENT OPINION IN PHARMACOLOGY (2011)
Creeping baselines and adaptive resistance to antibiotics
Lucia Fernandez et al.
DRUG RESISTANCE UPDATES (2011)
Optimization of meropenem dosage in the critically ill population based on renal function
Jared L. Crandon et al.
INTENSIVE CARE MEDICINE (2011)
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
Anna Skiada et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Pseudomonas aeruginosa: all roads lead to resistance
Elena B. M. Breidenstein et al.
TRENDS IN MICROBIOLOGY (2011)
Adaptive Resistance to the Last Hope Antibiotics Polymyxin B and Colistin in Pseudomonas aeruginosa Is Mediated by the Novel Two-Component Regulatory System ParR-ParS
Lucia Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
Juergen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS
Britt Jansson et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa
Todd A. Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
N. Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
Glenn A. Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mathematical modelling response of Pseudomonas aeruginosa to meropenem
Vincent H. Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments
Elisabet I. Nielsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
F Timurkaynak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
S Mizunaga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Modelling time-kill studies to discern the pharmacodynamics of meropenem
VH Tam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin
AK Meagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes
N Ahmed et al.
CEREBROVASCULAR DISEASES (2003)
Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation
A Chakraborty et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Share Paper
